3SOF

My pick is EZM

Reasons behind it:

1. Strong ER was just reported.

EuroZinc Mining Corporation ("EuroZinc" or "the Company") today announced financial results for the fourth quarter and year ending December 31, 2005. Colin K. Benner, Vice Chairman and CEO of EuroZinc commented that, "The investment in Neves-Corvo has been significant for EuroZinc. In the 18 months the Company has owned the Neves-Corvo mine we have repaid almost the entire amount of the acquisition debt, all monies borrowed to acquire the price participation rights and are now accumulating cash. The mine operated in 2005 at production levels beyond what was believed achievable in our due diligence. The operating costs in the mine have remained constant despite inflationary pressures, and the robust copper price has made an extraordinary contribution to our balance sheet, as it has to others in the copper business. The timeliness of the acquisition of Neves-Corvo and the quality of the asset has exceeded the expectations of many. We believe the continued strong copper market, and the addition of zinc production in the near term in a strong zinc market bodes well for the future of the Company and for its shareholders."

Highlights for 2005 and Fourth Quarter

- Achieved record revenue of $314.9 million on sales of 203.7 million pounds of copper for the year and $97.5 million on sales of 48.1 million pounds for the fourth quarter;

- Achieved record net earnings of $88.3 million or US$0.17 (Cdn$0.20) per share for the year and $27.8 million or US$0.05 (Cdn$0.06) for the fourth quarter;

- Generated cash flow from operations, before working capital changes, of $131.4 million or US$0.25 (Cdn$0.30) per share for the year and US$0.09 (Cdn$0.10) for the fourth quarter;

- Initiated an aggressive $10 million exploration program in Portugal;

- Repaid $86.3 million of debt in 2005;

- Strengthened the balance sheet by reducing the net debt to equity ratio to 7% at the 2005 year end from 73% at the beginning of the year;

- Purchased the balance of the vendors' price participation rights in 2005 and repaid the related loan in eight months;

- Listed on the American Stock Exchange.

"We are both pleased and proud of our first full year of work as a new team in Portugal and in EuroZinc," said Joao Carrelo, Managing Director of Somincor, EuroZinc's wholly owned subsidiary that owns the Neves-Corvo mine. Mr. Carrelo added, "This was our first full year as a mine operating entity in Portugal, managing Europe's second largest copper mine. The management and employees of Neves-Corvo achieved a 14 percent improvement, year over year, in tonnes mined and an 8 percent improvement in tonnes milled, and did so with no additional manpower, equipment or change in the working schedules."

2. Zinc price will be going up continuously.

MY pick Is MANU
Manugistics Group, Inc. (Manugistics) is a provider of supply chain, demand and revenue management software products and services. The Company's solutions are configured sets of its software products that address the specific demand and supply chain business processes and revenue management practices that its clients want to improve. These solutions may also include consulting, implementation, training and client support services. Manugistics solutions are built on and rely on its internal WebWORKS platform. WebWORKS is based on the Java 2 Platform and Java2EE industry standards. The solution sets the Company offers are Demand Management and Pricing, Supply Management, Transportation and Logistics, Collaboration and Visibility, Contract Materials Resource Planning & Maintenance, Repair and Overhaul, Performance Management and Revenue Management. The Company markets its solutions to companies throughout North, South and Central America, Europe and the Asia-Pacific region.
Company recently introduced Supply chain tune up program.Company that use this approach will see a 5-10% improvement in forecast accuracy and 1-5% in supply chain costs
company actually missed the earnings reported on 1/6/2006 yet the price went up since than.
company announced that they will reduce head count in America and increase head count in India reducing development cost by 2-3 million /qtr.Signed a deal with SOMERFIELD(UK supermarket chain with1224 stores).Started working with IBM to develop innovative tech.for IBM's websphere e-business platform.

Technically :
   Rsi went from 48 to 62 in 12 months , Money flow increased in the same time period .Broke the consolidation chanel now breaking the ascending triangle.

My Pick is---LOOK---Looksmart LTD.

  Chart is looking great!! Looks ready to break the 5.00 mark soon and when it does expect quick movement up. Looking at the chart you see an ascending triangle forming, considered a very bullish formation. Timeline for resistance break should be 1-3 weeks.

•  Stock Pick:
AVNX Avanex Corp.

•  Stock Profile:
Avanex is a leading global provider of Intelligent Photonic Solutions. Avanex meets the needs of fiber optic communication networks by enabling greater capacity, longer distance transmission, improved connectivity, higher speeds and lower cost.

These solutions enable or enhance optical wavelength multiplexing, dispersion compensation, switching and routing, transmission, amplification, and network managed subsystems.

Headquartered in Fremont, CA, Avanex maintains facilities in Elmira, NY; Nozay, France; San Donato, Italy; and Shanghai, China. The facilities are home to Avanex's Centers of Excellence for specialized research. A world-class manufacturing operation resides in Bangkok, Thailand.

•  Reason behind this pick
AVNX has had a nice spike up in the past 3 days due to some good PR this past week
02/28: Announced the release of a hot-pluggable EDFA (enable simple field upgrades or healing stressed links; it significantly reduces the cost, development time, management and complexity of adding amplification to terminal equipment)
03/01: Announced the introduction of the 1901FBF PowerBragg(TM) Supervisory Channel Filter for Fiber to the Home (FTTH) applications (allows automatic and accurate identification of network faults, whichs enables faster network recovery and the prompt restoration of subscriber services)
03/02: Announced the availability of an industry leading optical performance monitoring (OPM) product portfolio (provides a one-stop solution for OEM and carrier customer optical performance monitoring needs)
03/03: Announced the introduction of its SD10-DP and SD40-DP Lithium Niobate modulators for the Differential Quadrature Phase Shift Keying (DQPSK) modulation format (an ideal format for ultra-long-haul and submarine transmission)

This is all a little bit gibrish for me too, but it all means that they are finally coming out with products that are going to generate profit for the company.
Analysts growth estimates are as follow:
Current Qtr.    61.5%
Next Qtr.        72.7%
This Year        46.9%
Next Year     126.9%

I think AVNX will show a good short term increase

•  Stock Chart

1) GNBT --- GENEREX BIOTECH CORP

2) Business summary:
Generex Biotechnology Corporation engages in the research and development of drug delivery systems and technology. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company's primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Gluco-gyn, a formulated glucose spray used for the treatment of hypoglycemia in people with diabetes, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the company develops technology for the oral administration of molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. It also engages in the research and development of technologies and immunomedicines for the treatment of malignant, infectious, autoimmune, and allergic diseases.

Its another bird flu momentum play , unfortunately. Altho the company has other products in the pipeline. the Company's flagship product, Generex Oral-lyn™, is the first application for RapidMist and is currently in late stage clinical trials around the world. It recently had good news:
Generex Biotechnology Completes Positive Pre-NDS Meeting With Health Canada for Generex Oral-lyn(TM) http://biz.yahoo.com/iw/060303/0111920.html

Also ,they have been developing an avian-flu vaccine candidate based on its Antigen Express technology. The company presented at the two-day Bird Flu Summit, a conference on the threat of an international pandemic featuring public- and private-sector speakers last week. GNBT and BCRX were 2 major players in the conference.

Last week the company received 11 million from warrant exercises, but the dilution didnt bring down the stock much . on the other hand, the receipt of these funds has put the Company's cash-on-hand at more than $31 million, its strongest cash position in more than four years. I expect any positive PR or bird flu news would push the stock up.

3) chart:

Xwg looks prepared for a breakout. I've owned and sold this baby at least 10 times in the past.

My pick - NWD( New Dragon Asia Corp.)
Sector: Consumer Goods, Industry: Processed & Packaged Goods

Company - This company mills, sells and distributes flour and related products to retail and commercial customers throughout China.

In January, NWD agreed to purchase a company that controls a state-owned noodle manufacturing facility in Chengdu, Sichuan Province, for about $3.3 million.The acquisition, in the western region of China, complements the company's presence in eastern and northern China. NWD expects production at this facility to begin in the second quarter of 2006. Also in December, the company acquired Shandong Xinlongya Distribution Co. Ltd.The acquisition is expected to enhance the profitability of the company's export business by $400,000 on a 12-month basis with export sales increasing to 12% in 2006, from 8% in 2005. In April, the company acquired a 10-year lease agreement for plant and machinery utilized for the production of soybean-derived products. The company estimated that this new line of business would contribute at least $5 million to 2005 revenue.

Reasons for the Pick
(1) Solid Costomer base, noodles to Chinese is like breads to American;
(2) Acquisitions position from regional to statewide and increased export sales;
(3) In IBD top lists several weeks;
(4) Recent pullback to fill the gap due to lack of News.
(5) Quarter report in 03/28 should stimulate movements.

SCU  --  STORM CAT ENERGY CORP - American Stock Exchange
http://www.stormcatenergy.com/

SCU has pulled back and testing a trendline under the lows back to November 2005. Technical indicators are still down but many are moving to oversold. SCU has a $32 million budget for drilling, leasehold and geologic work in 2006. Has producing wells in its Powder River Basin properties. LOI to acquire more CBM properties to drill and bring into production. Properties in Alaska and Canada. The Elk Valley project in BC can be very large and important. SCU is producing and selling CBM gas.

Wow, alot of people aren't reading the rules this time around.

Anyway, my stock pick for this 4th edition will be AOB.

I was thinking about going with a bird flu play, CBMX to be precise, for this contest seeing how its been on fire lately but I'm going to look at AOB as a bird flu hype play.  AOB's product line includes nutritional supplements which are claimed to strengthen the immune system.  They even go as far as to claim that it will help protect a person from contracting bird flu.  I would guess that these are unsubstantiated claims but if it helps move the share price, so be it.

Technically I am hoping for a bounce off of the 50 MA upon which it is currently resting.  I would wait for a confirmation of this before purchasing, but seeing how the contest starts on Monday, I don't have that luxury.

LVLT : Level Three Comm.
I really liked chart it show's cup formed and I'm expecting handle to come.  higher volume than the previous day for the last five day's with MACD crossover on the last trading day of almost 60 million shares for that day. How much more bullish can a chart show?

bizjournals.com
Level 3 subsidiary plans $400M offering
Friday March 3, 1:39 pm ET
Level 3 Communications Inc. plans to raise $400 million in a private offering of senior notes through a subsidiary, Level 3 Financing Inc.
The Broomfield-based telecom company (NASDAQ: LVLT - News) said it will use the proceeds to finance the cash purchase price of WilTel Communications Group LLC and the proposed acquisition of Progress Telecom LLC. Level 3 closed in December on its purchase of WilTel, for which it paid $386 million and 115 million shares of its stock.
  Level 3 in January announced an agreement to buy Progress Telecom for a total of $137 million -- $68.5 million in cash and $68.5 million of unregistered shares of stock. The company expects the deal to close in the second quarter.
Level 3 said the offering to qualified institutional investors should be completed the week of March 14. The offering will be made in two tranches, one of which will mature in 2011 and a second that will mature in 2013. The allocation between the two hasn't been determined yet.

1. Northgate Minerals Corp (NXG)

2. Northgate Minerals is a gold and copper mining and development company with assets in BC, Canada.  This stock has been on a serious bull run and this news came out a couple of weeks ago: Northgate Reports Record Quarterly Earnings and Cash Flow and Announces That its Project Debt Facility Has Been Retired.  I don't think we have seen the end to rising gold and copper prices.  Northgate's assets make it well positioned to continue it's record earnings.

3.  Technically, the stock has shown increasing volume recently and is approaching it's all time high price of $2.58.  Although not perfect technically, we also have something of a cup and handle formation with volume following the shape of the cup as should happen.

* MPH's cash and cash equivalents... $13,756,000 at January 4, 2006.
* Their Burn Rate is on average $2.5 mil Cdn or $2.1 mil US/qtr.
* Phase 2 and Phase 3 trials are being designed in very close consultation with the FDA to ensure the strictest guidelines are adhered to.
* MPH Currently holds 15 Patents and 17 more are pending.
* MPH was granted "Fast Track Status" on Sept.5/05 for it's Cardioprotective Lead Drug MC-1.
* MPH is using a unique intravenous MC-1 formulation in it's Ph2 and Ph3 trials as necessary for the most acute cases to administer the drug in the fastest means possible to ensure the quickest absorbtion rate by the body.
MC-1 is being tested for it's affects on:
~CABG - Coronary Artery Bypass Graft Surgery
~ACS - Acute Coronary Syndrome
~AMI - Acute Myocardial Infarction (heart attacks)
~Stroke as well as Angioplasty

MC-4232 is being tested for it's affects on:
~Hypertension - (Abnormally High Blood Pressure)
~Diabetes

MC-4262 is being tested for it's affects on Metabolic Syndrom.

MC-45308 is being tested for it's affects on Thrombosis (Clots in blood vessels).

MC-5422 is being tested for it's affects on Ischemic Reperfusion.

****MPH's drug Candidate MC-45308 in preclinical research is considered a Breakthough in preventing blood clots as it has demonstrated both Anti-platelet and Anti-coagulant effects...

Dr Friesen stated "A drug of this nature currently is non existent within the Antithrombotic marketplace!"

****Sept.14/05 MPH announced positive Ph2 results for their drug MC-4232 in a matched study with MC-1 and the Ace Inhibitor Lisinopril in the treatment of patients with coexisting diabetes and hypertension, and demonstrated it was safe and well tolerated at all dose levels.

Dr Friesen stated "The Matched trial has exceeded our expectations, demonstrating the outstanding clinical benefits of MC-4232!"

****Dec.5/05 MPH announced positive Ph2 results for MC-1 in the MEND-CABG Trial with amazing results such as the 46.9% reduction in non fatal Myocardial Infarction.

Dr. Friesen stated "The strong efficacy signal observed with MC-1 in MEND-CABG, highlighted by the statistically significant reduction in heart attacks, have exceeded our own expectations, and clearly warrants advancing MC-1 into Pivotol Ph3 developement.

They're expecting a TON of news in a very short period of time. Likely by the end of March or April we will have announcements on all of the following:

1) MC-1 Phase3 begins for MEND-CABG and Matched studies for ACS.
2) MC-4232 Phase3 begins.
3) MC-4262 Phase2 begins.
4) MC-45308 Phase1 begins.
5) MC-5422 Pre-Clinical Trials begin.
6) Results of Phase2, MC-1 MEND-CABG, Post Operative 90 day data.
7) Partnership agreement for the Phase3 trials with a Large Pharma.

It's absolutely incredible how everything is coming together at the same time, and most investors are thinking of only one or two potential news releases. Geeeesh. When this thing blows, it'll blow the top off the Biotech Sector Lid. There's just so much on the plate here I can't comprehend how Dr.Friesen and the management team keep it all organized. If there's delays, I understand why. Keep in mind as well that these potential announcements don't even include the rest of the "Behind the Scenes" stuff such as other R&D, Running the day to day business, obtaining new Board members, upcoming Patents not yet recieved but applied for, Biotec Conferences etc....

We're sitting on a Powder Keg and the fuse is lit!!

Medicure has a Great Website...... http://www.medicure.com/

Cheers..... Dead

http://stockcharts.com/def/servlet/Favorites.CServlet?obj=ID871828

My pick: GTE (GlobeTel Communications Corp.)

GTE provides telecommunication services. It  owns SANSWIRE NETWORKS LLC, which  is developing a technology to  provide wireless broadband Network utilizing blimp like airships called Stratellites.
Two months ago, it signed a  $600 Million Contract to install broadband phone services  in  30 Russian Cities. The share price reached around $4.00. Since then, a couple of Motley fool articles as well as  delay in receiving the  $150 million initial payment has caused the  share price to drop. Yesterday, in an update, GTE informed that the closing of the banking transaction is expected to be finalised in the next few days. News of them receiving the initial payment, should boost the confidence of  investors in this so novel technology and I expect the share price to go up to $4 and resume its upward march.
GTE was also Lucas Scott's choice in the first stock picking contest. It got him the first place. Maybe it still has another win left in it!!!

The chart is here: http://stockcharts.com/h-sc/ui?s=gte


Print - Annotate - Send - Linkable Version - Instructions - Report Problems

1) My Pick: MEK  Metretek

2) Reasons: Metretek's PowerSecure Subsidiary receives record 75 million in orders,in the article they talk about their powerSecure team whatever that is, but I'am sure it must be comparable to the Swedish hockey team.The company is involved with the design and construction of electronic generation equipment.Anyway I bought the sucker and I hope it moves out.
Chart shows strong ascending trendline with breakaway gap on high volume. Seems to be ignoring overbought condition. Macd very bullish indication.

3) Chart:

1)My pick: ICCA  - Internet Commerce Corp.

2) Reason: The reason of this pick is very simple;  the growth of the sales in the last quarters
5.000 - 5.100 -  4.400 - 3.500 - 3.700 (all numbers in thousands)
and the relative growth of the earnings in the same periods
$ 0.03 - $0.03 - $0.01 - $(-0.02) - $(-0.03)
in the last quarter Thomas J. Stallings said :"Our team remains focused on solid execution within each segment, committed to serving the needs of customers and dedicated to our 'Growth with Profitability' strategy. With the acquisition of The Kodiak Group, we have heightened our focus on providing a single source for strategic e-commerce initiatives. We are excited by the interest clients are expressing and expect to see continued revenue growth in the second quarter."

3) view the up channel